In the TRIUMPH-1 obesity trial (topline 21 May 2026), the 12 mg dose produced a mean weight loss of roughly 28% at 80 weeks in patients without diabetes, extending to close to 30% by 104 weeks in a severe-obesity extension cohort among the largest sustained pharmacological weight-loss effects reported in any trial to date
Elevate your protocols with a diluent you can trust
A third group was treated with 3 cycles of ozone therapy by rectal insufflation (RI)
Bottom Line : The FDA hasnt approved it for anything specific, but glutathione IV therapy looks promising for certain health problems, though many wellness claims dont have solid proof yet
Whilst glutathione and niacinamide are active ingredients, they work steadily rather than aggressively, and the formula includes calming ingredients like glycyrrhiza and panthenol
Microcirculation disturbance affects rats with acute severe pancreatitis following lung injury